filsuvez
(birch triterpenes)Amryt Pharmaceuticals DAC
Usage: FILSUVEZ is indicated for treating wounds related to dystrophic and junctional epidermolysis bullosa (EB) in adults and pediatric patients aged 6 months and older.
3 results
juxtapid
(lomitapide mesylate)Amryt Pharmaceuticals DACUsage: JUXTAPID is indicated as an adjunct therapy to a low-fat diet and other lipid-lowering treatments for reducing LDL-C, total cholesterol, apo B, and non-HDL-C in patients with homozygous familial hypercholesterolemia (HoFH). Its safety and effectiveness are not established for other hypercholesterolemia types.myalept
(metreleptin)Amryt Pharmaceuticals DACUsage: MYALEPT (metreleptin) is indicated as an adjunct to diet for replacing leptin to treat complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. It is not indicated for partial lipodystrophy, liver disease, HIV-related lipodystrophy, or metabolic diseases without generalized lipodystrophy.